体外受精中获卵数:疗效与安全性之间的平衡
这项基于瑞典国家质量登记处的回顾性人群登记研究纳入39 387名女性共77 956个新鲜IVF周期,分析获卵数与累计分娩率、重度卵巢过度刺激综合征(OHSS)及血栓栓塞事件的关系。累计分娩率随获卵数增加至约20个后趋于平稳,达45.8%;重度OHSS发生率从约18个卵起更快上升,血栓栓塞事件罕见但多见于获卵≥15个时。
要点
- 累计分娩率随获卵数增加至约20个后趋于平稳,达45.8%。
- 重度OHSS发生率随获卵数显著增加,尤其获卵数超过18个时。
- 血栓栓塞事件罕见,共14名患者发生16次事件,多见于获卵≥15个时。
核心结论
- 获卵数约18-20个时累计分娩率趋于平稳,同时重度OHSS发生率更快上升,血栓栓塞事件虽罕见也应纳入IVF刺激方案考量。
研究设计与样本
- 回顾性人群登记研究,纳入2007-2013年77 956个新鲜IVF周期(39 387名女性)及2007-2014年36 270次连续冻融胚胎移植。
- 数据来自瑞典国家辅助生殖质量登记处(Q-IVF),并与国家患者登记处链接获取重度OHSS和血栓栓塞事件的ICD-10诊断编码,排除卵子捐赠周期。
主要发现
- 新鲜周期活产率随获卵数增加至11个后趋于平稳,34岁女性活产率为30.3%。
- 每个取卵周期的累计分娩率(含新鲜移植及后续全部冻融胚胎移植)随获卵数增加至约20个,达45.8%。
- 活产随获卵数的校正比值比(AOR)为1.064(95%CI:1.061;1.067)。
- 重度OHSS发生率随获卵数显著增加,获卵数超过18个时尤为明显;OHSS随获卵数的AOR为1.122(95%CI:1.08;1.137)。
- 血栓栓塞事件罕见,14名患者共发生16次事件,多见于获卵数≥15个时。
临床怎么用
- 作者认为结果提示获卵数约18-20个时累计分娩率趋于平稳而重度OHSS发生率更快上升,血栓栓塞事件虽罕见也应在IVF刺激方案中予以考虑。
局限性
- 所有冻融胚胎移植周期可能未被全部纳入。
- 2010-2013年间冷冻保存的部分胚胎至2018年前仍可能产生额外活产。
- 研究期间Q-IVF登记处未收录促性腺激素剂量,因此无法对剂量进行调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the relationship between the number of oocytes collected in fresh IVF treatments and the likelihood of cumulative delivery rate (fresh and frozen) per oocyte aspiration, severe ovarian hyperstimulation syndrome (OHSS) and thromboembolic events? SUMMARY ANSWER: Cumulative delivery rate per aspiration increases up to 20 oocytes retrieved and then evens out while the incidence of severe OHSS increases more rapidly from around 18 oocytes and thromboembolic events, although rare, occurs in particular if 15 or more oocytes are retrieved. WHAT IS KNOWN ALREADY?: Previous studies have shown that the number of oocytes retrieved for IVF is a positive predictor of live birth in fresh cycles. Few studies have investigated cumulative live birth rates and OHSS in relation to the number of aspirated oocytes. STUDY DESIGN, SIZE, DURATION: Retrospective population-based registry study including 39 387 women undergoing 77 956 fresh IVF cycles in the period 2007-2013 and 36 270 consecutive transfers of frozen/thawed embryos in the period 2007-2014. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data from The Swedish National Quality Registry of Assisted Reproduction (Q-IVF) including all IVF cycles with oocyte retrieval performed in public or private infertility clinics during the study period, was cross-linked to the National Patient Register regarding diagnostic codes (ICD 10) for severe (OHSS) and thromboembolic events. Oocyte donation cycles were excluded. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth delivery rate in fresh cycles increased up to 11 oocytes retrieved and then evened out, where the live birth rate was 30.3% for a 34-year-old woman. The cumulative delivery rate per aspiration, including fresh transfer and all subsequent transfers of frozen-thawed embryos (FET cycles) per oocyte retrieval, increased up to approximately 20 oocytes where it reached 45.8%. The adjusted odds ratio (AOR) for live birth by the number of oocytes was 1.064 (95% CI: 1.061; 1.067). The incidence of severe OHSS increased significantly by the number of oocytes, particularly if more than 18 oocytes were retrieved. The AOR for OHSS by the number of oocytes was 1.122 (95% CI: 1.08; 1.137). Thromboembolic events were rare, a total of 16 events in 14 patients were observed, and occurred in particular if 15 or more oocytes were retrieved. LIMITATIONS, REASONS FOR CAUTION: All FET cycles might not be included. Some embryos cryopreserved between 2010 and 2013 might still result in additional births until 2018. Furthermore the gonadotrophin dose was not included in the Q-IVF Registry in the study period, thus adjustment for dose was not possible. WIDER IMPLICATIONS OF THE FINDINGS: The results suggest a shift at approximately 18-20 oocytes where the cumulative delivery rate per aspiration levels off and, at the same time, the incidence of severe OHSS increases more rapidly. Thromboembolic events, although rare, should also be taken into consideration at stimulation regimes for IVF. Evaluating data taking both efficacy and the most serious safety aspects into account, is a new approach and of crucial importance both for patients undergoing IVF and their physicians. STUDY FUNDING/COMPETING INTEREST: Financial support was received through an agreement relating to research and the education of doctors (ALFGBG-70 940) and grant from the Hjalmar Svensson Research Foundation. None of the authors declares any conflict of interest.
引用
- Magnusson Å, Källen K, Thurin-Kjellberg A, et al. The number of oocytes retrieved during IVF: a balance between efficacy and safety. Hum Reprod. 2018. PMID: 29136154. doi:10.1093/humrep/dex334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。